Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endonovo Therapeutics Inc (OTCQB:ENDV.PK)

0.08
Delayed Data
As of Aug 28
 0.00 / 0.00%
Today’s Change
0.05
Today|||52-Week Range
2.50
-93.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

--
Revenue and IncomeNet Revenues30.6K22.9K24.2K--
 
 
 
 
Cost of Goods Sold--2.0K15.5K--
 
 
 
Depreciation And Amortization37.0K12.0K15.7K--
 
 
 
 
 
Operating ExpensesGross Income--8.9K-7.0K--
 
 
 
General Expenses1.7M2.4M2.2M--
 
 
 
 
Total Operating Expenses1.8M2.5M2.2M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.7M-2.4M-2.2M--
 
 
 
 
Extraordinary Charge-155.0K-197.8K0.00--
 
 
 
Interest Expense On Debt113.5K267.6K178.8K--
 
 
 
 
Other Expenses96.3K1.8K1.4M--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-2.9M-959.5K--
 
 
 
 
Income Taxes0.00-532.000.00--
 
 
Net Income-1.9M-2.9M-959.5K--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS481.4K697.3K30.3M--
 
 
 
 
Shares To Calculate EPS Diluted481.4K697.3K30.3M--
 
 
 
 
 
Earnings Per ShareEPS-$4.00-$4.00-$0.03--
 
 
 
 
EPS Diluted-$4.00-$4.00-$0.03--